International Patent: BINDING MOLECULE SPECIFICALLY BINDING TO ANTI-NPR1 ANTIBODY AND MEDICAL USE THEREOF

GENEVA, July 1 -- JIANGSU HENGRUI PHARMACEUTICALS CO., LTD. filed a patent application (CN2025/141771) for “BINDING MOLECULE SPECIFICALLY BINDING TO ANTI-NPR1 ANTIBODY AND MEDICAL USE THEREOF”. With publication no. WO/2026/124589, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C07K 16/42

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....